|
TMEM38B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.03670003084966E-09 |
| Normal-vs-Stage3 |
8.64353033591669E-12 |
| Normal-vs-Stage4 |
1.677070E-03 |
| Stage1-vs-Stage2 |
5.555800E-01 |
| Stage1-vs-Stage3 |
7.625000E-01 |
| Stage1-vs-Stage4 |
2.434500E-02 |
| Stage2-vs-Stage3 |
7.505200E-01 |
| Stage2-vs-Stage4 |
3.411900E-02 |
| Stage3-vs-Stage4 |
8.618100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.9567016330011E-11 |
| Normal-vs-Asian |
2.969000E-04 |
| Caucasian-vs-AfricanAmerican |
4.687500E-02 |
| Caucasian-vs-Asian |
6.682800E-01 |
| AfricanAmerican-vs-Asian |
7.987600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
7.43369810152217E-11 |
| Male-vs-Female |
1.419150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.85151935186923E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
3.574918139293E-14 |
| Normal-vs-Extreme_Obese |
2.14889999999857E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.172180E-01 |
| Normal_Weight-vs-Obese |
8.799600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.372600E-01 |
| Extreme_Weight-vs-Obese |
5.030400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.102200E-01 |
| Obese-vs-Extreme_Obese |
8.910000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.04250000246375E-08 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.35009999957525E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.497400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.653200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.006000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.467000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.673800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.679800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.24531504500192E-12 |
| Normal-VS-Type2 PRCC |
9.54169998568233E-09 |
| Normal-VS-KIRP CIMP |
8.2078000000041E-05 |
| Normal-VS-Unclassified PRCC |
9.74120784036359E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.202050E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.369800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.605600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.568600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.082100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.525400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51212375953946E-12 |
| Normal-vs-N1 |
5.80610004519144E-09 |
| Normal-vs-N2 |
7.988600E-04 |
| N0-vs-N1 |
9.716200E-01 |
| N0-vs-N2 |
6.584200E-01 |
| N1-vs-N2 |
6.515000E-01 |
|
|
